• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    9/15/23 11:52:24 AM ET
    $PLNT
    $PLRX
    $PMF
    $PML
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PLNT alert in real time by email

     

    Friday's session saw 169 companies set new 52-week lows.

    Points of Interest From Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.
    • Blue Star Foods (NASDAQ:BSFC) was the smallest company in terms of market cap to set a new 52-week low.
    • PTC Therapeutics (NASDAQ:PTCT)'s stock fell the most, as it traded down 31.29% to reach a new 52-week low.
    • Prelude Therapeutics (NASDAQ:PRLD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    On Friday, the following stocks set new 52-week lows:

    • Bristol-Myers Squibb (NYSE:BMY) stock dropped to a yearly low on Friday of $58.92. Shares traded down 0.87%.
    • Realty Income (NYSE:O) shares reached a new 52-week low of $54.29 on Friday morning, moving down 1.42%.
    • Illumina (NASDAQ:ILMN) stock hit a yearly low of $145.14. The stock was down 3.41% for the day.
    • ResMed (NYSE:RMD) stock hit $145.74 on Friday morning, setting a new 52-week low for a change of down 0.98%.
    • Royalty Pharma (NASDAQ:RPRX) shares made a new 52-week low of $28.21 on Friday. The stock was down 1.67% for the day.
    • Insulet (NASDAQ:PODD) stock hit $166.03 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • Chewy (NYSE:CHWY) stock set a new 52-week low of $20.48 on Friday, moving down 2.75%.
    • TKO Group Holdings (NYSE:TKO) shares fell to $99.24 on Friday, setting a new 52-week low with a shift of down 1.27%.
    • SolarEdge Technologies (NASDAQ:SEDG) stock hit a new 52-week low of $141.67. The stock was down 1.29% on the session.
    • Liberty SiriusXM Gr (NASDAQ:LSXMB) shares reached a new 52-week low of $22.19 on Friday morning, moving down 3.38%.
    • Agree Realty (NYSE:ADC) shares set a new 52-week low of $59.51. The stock traded down 0.9%.
    • Envista Holdings (NYSE:NVST) shares made a new 52-week low of $28.74 on Friday. The stock was down 0.62% for the day.
    • Planet Fitness (NYSE:PLNT) stock dropped to a yearly low on Friday of $50.21. Shares traded down 15.17%.
    • Cava Group (NYSE:CAVA) stock broke to a new 52-week low of $34.42 on Friday. Shares of the company traded down 3.66%.
    • Medical Properties Trust (NYSE:MPW) stock achieved a new 52-week low on Friday morning, hitting $6.28 and moving down 3.72%.
    • PNM Resources (NYSE:PNM) stock broke to a new 52-week low of $43.64 on Friday. Shares of the company traded down 0.22%.
    • Savers Value Village (NYSE:SVV) shares fell to $19.61 on Friday, setting a new 52-week low with a shift of down 2.02%.
    • Physicians Realty Trust (NYSE:DOC) shares hit a yearly low of $12.94. The stock was down 3.03% on the session.
    • Macy's (NYSE:M) stock hit $11.15 on Friday morning, setting a new 52-week low for a change of down 1.54%.
    • Tower Semiconductor (NASDAQ:TSEM) stock dropped to a yearly low on Friday of $27.23. Shares traded down 2.22%.
    • Galapagos (NASDAQ:GLPG) stock dropped to a yearly low on Friday of $36.00. Shares traded down 0.11%.
    • PTC Therapeutics (NASDAQ:PTCT) shares set a new yearly low of $24.43 this morning. The stock was down 31.29% on the session.
    • Grupo Televisa (NYSE:TV) stock set a new 52-week low of $3.41 on Friday, moving down 2.01%.
    • Mister Car Wash (NYSE:MCW) shares hit a yearly low of $6.04. The stock was down 1.61% on the session.
    • Peloton Interactive (NASDAQ:PTON) shares hit a yearly low of $4.96. The stock was down 2.43% on the session.
    • Spirit AeroSystems Hldgs (NYSE:SPR) shares were up 1.28% for the day, having made a 52-week low of $16.28.
    • Silicon Motion Technology (NASDAQ:SIMO) shares set a new 52-week low of $50.51. The stock traded down 1.35%.
    • Supernus Pharmaceuticals (NASDAQ:SUPN) shares set a new 52-week low of $28.77. The stock traded down 1.13%.
    • ZIM Integrated Shipping (NYSE:ZIM) shares set a new yearly low of $11.15 this morning. The stock was up 0.45% on the session.
    • Amylyx Pharma (NASDAQ:AMLX) shares set a new yearly low of $19.36 this morning. The stock was up 0.25% on the session.
    • Petco Health and Wellness (NASDAQ:WOOF) stock drifted down 3.78% on Friday morning to hit a new 52-week low of $4.44.
    • Syndax Pharmaceuticals (NASDAQ:SNDX) stock hit a yearly low of $16.76. The stock was down 0.21% for the day.
    • Netstreit (NYSE:NTST) stock broke to a new 52-week low of $16.62 on Friday. Shares of the company traded up 0.3%.
    • Phreesia (NYSE:PHR) stock hit a new 52-week low of $19.52. The stock was down 1.44% on the session.
    • Pliant Therapeutics (NASDAQ:PLRX) shares reached a new 52-week low of $15.82 on Friday morning, moving down 0.56%.
    • Olo (NYSE:OLO) shares set a new 52-week low of $5.63. The stock traded down 0.44%.
    • Definitive Healthcare (NASDAQ:DH) stock set a new 52-week low of $8.07 on Friday, moving down 1.21%.
    • Tekla Healthcare (NYSE:HQH) stock set a new 52-week low of $15.96 on Friday, moving down 0.68%.
    • GDEV (NASDAQ:GDEV) stock achieved a new 52-week low on Friday morning, hitting $3.09 and moving down 9.33%.
    • Gogoro (NASDAQ:GGR) stock drifted down 0.55% on Friday morning to hit a new 52-week low of $2.67.
    • Silk Road Medical (NASDAQ:SILK) stock broke to a new 52-week low of $16.72 on Friday. Shares of the company traded down 1.52%.
    • DocGo (NASDAQ:DCGO) stock drifted down 5.11% on Friday morning to hit a new 52-week low of $5.76.
    • PIMCO Income Strategy (NYSE:PFN) stock broke to a new 52-week low of $6.63 on Friday. Shares of the company traded up 0.15%.
    • FuelCell Energy (NASDAQ:FCEL) stock broke to a new 52-week low of $1.23 on Friday. Shares of the company traded down 3.02%.
    • PIMCO Municipal Income (NYSE:PML) stock achieved a new 52-week low on Friday morning, hitting $8.28 and moving up 0.35%.
    • Nuveen California (NYSE:NKX) stock hit $10.71 on Friday morning, setting a new 52-week low for a change of down 0.28%.
    • Consensus Cloud Solutions (NASDAQ:CCSI) shares set a new yearly low of $25.05 this morning. The stock was down 2.26% on the session.
    • Theravance Biopharma (NASDAQ:TBPH) shares set a new yearly low of $9.05 this morning. The stock was down 5.77% on the session.
    • Lyell Immunopharma (NASDAQ:LYEL) stock set a new 52-week low of $1.66 on Friday, moving down 1.72%.
    • Perfect (NYSE:PERF) stock dropped to a yearly low on Friday of $3.21. Shares traded down 7.28%.
    • Seres Therapeutics (NASDAQ:MCRB) shares moved down 2.2% on Friday to hit a new 52-week low of $2.83, drifting down 2.2%.
    • Eaton Vance Municipal IT (NYSE:EVN) stock hit a yearly low of $9.26. The stock was up 0.22% for the day.
    • Butterfly Network (NYSE:BFLY) shares set a new yearly low of $1.61 this morning. The stock was up 8.57% on the session.
    • Aerovate Therapeutics (NASDAQ:AVTE) stock broke to a new 52-week low of $12.87 on Friday. Shares of the company traded down 5.14%.
    • Materialise (NASDAQ:MTLS) shares fell to $5.96 on Friday, setting a new 52-week low with a shift of down 1.32%.
    • QuantaSing Group (NASDAQ:QSG) shares were down 5.76% for the day, having made a 52-week low of $5.70.
    • TH International (NASDAQ:THCH) stock hit a yearly low of $1.93. The stock was down 2.99% for the day.
    • Expensify (NASDAQ:EXFY) stock set a new 52-week low of $3.56 on Friday, moving down 3.81%.
    • Nuvation Bio (NYSE:NUVB) shares were down 2.17% for the day, having made a 52-week low of $1.33.
    • SkyWater Technology (NASDAQ:SKYT) stock hit a yearly low of $6.06. The stock was down 1.77% for the day.
    • Nuveen Core Plus Impact (NYSE:NPCT) stock hit a new 52-week low of $9.51. The stock was down 0.15% on the session.
    • Citizens Financial Servs (NASDAQ:CZFS) stock broke to a new 52-week low of $49.69 on Friday. Shares of the company traded down 0.14%.
    • PIMCO Municipal Income (NYSE:PMF) shares hit a yearly low of $8.92. The stock was down 0.22% on the session.
    • Axogen (NASDAQ:AXGN) shares made a new 52-week low of $5.30 on Friday. The stock was down 2.44% for the day.
    • Fate Therapeutics (NASDAQ:FATE) shares set a new yearly low of $2.28 this morning. The stock was down 2.54% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares made a new 52-week low of $7.43 on Friday. The stock was down 2.86% for the day.
    • Gossamer Bio (NASDAQ:GOSS) stock broke to a new 52-week low of $0.84 on Friday. Shares of the company traded down 1.68%.
    • eGain (NASDAQ:EGAN) shares set a new yearly low of $5.80 this morning. The stock was down 4.13% on the session.
    • Blackrock Investment (NYSE:BKN) shares hit a yearly low of $10.61. The stock was down 0.38% on the session.
    • SIGNA Sports United (NYSE:SSU) shares moved down 6.3% on Friday to hit a new 52-week low of $0.45, drifting down 6.3%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) shares hit a yearly low of $5.44. The stock was down 0.7% on the session.
    • Prelude Therapeutics (NASDAQ:PRLD) stock drifted 0.0% (flat) on Friday morning to hit a new 52-week low of $3.07.
    • CoreCard (NYSE:CCRD) shares set a new yearly low of $20.01 this morning. The stock was down 0.74% on the session.
    • XIAO-I (NASDAQ:AIXI) shares fell to $2.17 on Friday, setting a new 52-week low with a shift of down 2.01%.
    • Gabelli Healthcare (NYSE:GRX) shares set a new yearly low of $9.10 this morning. The stock was down 0.22% on the session.
    • Skillz (NYSE:SKLZ) stock dropped to a yearly low on Friday of $6.32. Shares traded down 0.93%.
    • Zentek (NASDAQ:ZTEK) stock dropped to a yearly low on Friday of $1.19. Shares traded up 3.23%.
    • Lazydays Hldgs (NASDAQ:LAZY) shares set a new yearly low of $9.13 this morning. The stock was down 8.46% on the session.
    • Flaherty & Crumrine Prefd (NYSE:PFD) stock achieved a new 52-week low on Friday morning, hitting $9.41 and moving up 0.53%.
    • China Automotive Systems (NASDAQ:CAAS) stock drifted down 3.09% on Friday morning to hit a new 52-week low of $3.67.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock dropped to a yearly low on Friday of $1.29. Shares traded up 2.29%.
    • Honest Co (NASDAQ:HNST) stock hit $1.11 on Friday morning, setting a new 52-week low for a change of down 15.6%.
    • ContextLogic (NASDAQ:WISH) shares fell to $4.44 on Friday, setting a new 52-week low with a shift of down 1.74%.
    • Vacasa (NASDAQ:VCSA) stock broke to a new 52-week low of $0.40 on Friday. Shares of the company traded up 1.26%.
    • BioAtla (NASDAQ:BCAB) shares reached a new 52-week low of $2.03 on Friday morning, moving up 0.49%.
    • Sezzle (NASDAQ:SEZL) shares hit a yearly low of $14.01. The stock was down 7.2% on the session.
    • FibroGen (NASDAQ:FGEN) shares set a new yearly low of $0.88 this morning. The stock was down 2.54% on the session.
    • OFS Credit Co (NASDAQ:OCCI) shares made a new 52-week low of $7.26 on Friday. The stock was down 0.71% for the day.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares made a new 52-week low of $3.73 on Friday. The stock was up 0.53% for the day.
    • Clene (NASDAQ:CLNN) shares made a new 52-week low of $0.56 on Friday. The stock was down 5.51% for the day.
    • Rani Therapeutics Hldgs (NASDAQ:RANI) shares fell to $2.80 on Friday, setting a new 52-week low with a shift of down 4.11%.
    • Spectral AI (NASDAQ:MDAI) shares were down 6.3% for the day, having made a 52-week low of $3.60.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) stock hit a yearly low of $1.22. The stock was down 6.15% for the day.
    • Personalis (NASDAQ:PSNL) shares set a new 52-week low of $1.37. The stock traded down 0.77%.
    • Sol-Gel Technologies (NASDAQ:SLGL) stock set a new 52-week low of $2.16 on Friday, moving down 0.4%.
    • GEN Restaurant Gr (NASDAQ:GENK) shares made a new 52-week low of $12.59 on Friday. The stock was down 3.55% for the day.
    • Eargo (NASDAQ:EAR) stock hit a new 52-week low of $2.44. The stock was up 0.81% on the session.
    • Mira Pharmaceuticals (NASDAQ:MIRA) stock achieved a new 52-week low on Friday morning, hitting $3.41 and moving down 3.94%.
    • Brainstorm Cell (NASDAQ:BCLI) stock hit a yearly low of $0.95. The stock was down 5.0% for the day.
    • Lantern Pharma (NASDAQ:LTRN) shares set a new 52-week low of $4.00. The stock traded down 3.94%.
    • Prestige Wealth (NASDAQ:PWM) stock broke to a new 52-week low of $4.50 on Friday. Shares of the company traded down 4.88%.
    • Leap Therapeutics (NASDAQ:LPTX) stock hit a yearly low of $1.60. The stock was down 2.12% for the day.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPA) shares were down 1.68% for the day, having made a 52-week low of $0.52.
    • Brilliant Earth Group (NASDAQ:BRLT) stock hit a yearly low of $3.07. The stock was down 2.82% for the day.
    • Enlivex Therapeutics (NASDAQ:ENLV) shares reached a new 52-week low of $1.72 on Friday morning, moving down 4.77%.
    • PIMCO New York Municipal (NYSE:PYN) stock achieved a new 52-week low on Friday morning, hitting $5.67 and moving up 0.18%.
    • Solowin Holdings (NASDAQ:SWIN) stock hit a new 52-week low of $2.27. The stock was down 10.04% on the session.
    • Koss (NASDAQ:KOSS) stock broke to a new 52-week low of $3.35 on Friday. Shares of the company traded down 2.31%.
    • RF Industries (NASDAQ:RFIL) shares hit a yearly low of $2.92. The stock was down 18.11% on the session.
    • SEALSQ (NASDAQ:LAES) shares fell to $3.05 on Friday, setting a new 52-week low with a shift of down 6.39%.
    • Sunworks (NASDAQ:SUNW) stock broke to a new 52-week low of $0.68 on Friday. Shares of the company traded down 3.48%.
    • IN8bio (NASDAQ:INAB) shares were down 0.53% for the day, having made a 52-week low of $0.90.
    • OncoCyte (NASDAQ:OCX) shares set a new 52-week low of $3.18. The stock traded up 2.13%.
    • Alpine 4 Holdings (NASDAQ:ALPP) stock set a new 52-week low of $0.91 on Friday, moving down 2.79%.
    • VBI Vaccines (NASDAQ:VBIV) stock set a new 52-week low of $1.01 on Friday, moving down 2.75%.
    • Protara Therapeutics (NASDAQ:TARA) shares set a new 52-week low of $2.05. The stock traded down 0.45%.
    • Cyngn (NASDAQ:CYN) shares made a new 52-week low of $0.50 on Friday. The stock was down 7.89% for the day.
    • Phoenix New Media (NYSE:FENG) shares reached a new 52-week low of $1.12 on Friday morning, moving down 0.83%.
    • Vaccinex (NASDAQ:VCNX) shares set a new 52-week low of $0.17. The stock traded down 8.97%.
    • EZGO Technologies (NASDAQ:EZGO) shares reached a new 52-week low of $0.16 on Friday morning, moving down 3.61%.
    • PolyPid (NASDAQ:PYPD) shares fell to $0.24 on Friday, setting a new 52-week low with a shift of down 7.49%.
    • Intrusion (NASDAQ:INTZ) stock achieved a new 52-week low on Friday morning, hitting $0.50 and moving down 4.61%.
    • Talis Biomedical (NASDAQ:TLIS) shares hit a yearly low of $5.79. The stock was down 4.99% on the session.
    • Remark Hldgs (NASDAQ:MARK) shares moved down 1.59% on Friday to hit a new 52-week low of $0.51, drifting down 1.59%.
    • Inhibikase Therapeutics (NASDAQ:IKT) stock broke to a new 52-week low of $1.65 on Friday. Shares of the company traded up 1.19%.
    • BioCardia (NASDAQ:BCDA) shares hit a yearly low of $0.39. The stock was down 0.28% on the session.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $1.61. The stock was down 3.55% on the session.
    • Tempo Automation Holdings (NASDAQ:TMPO) stock dropped to a yearly low on Friday of $0.20. Shares traded down 2.86%.
    • ContraFect (NASDAQ:CFRX) stock hit a new 52-week low of $0.58. The stock was up 0.24% on the session.
    • Super League Enterprise (NASDAQ:SLE) shares set a new yearly low of $1.57 this morning. The stock was down 11.82% on the session.
    • Antelope Ent Hldgs (NASDAQ:AEHL) stock drifted down 6.12% on Friday morning to hit a new 52-week low of $0.30.
    • PaxMedica (NASDAQ:PXMD) shares set a new yearly low of $0.25 this morning. The stock was down 5.84% on the session.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $1.03. The stock was up 0.93% for the day.
    • Netcapital (NASDAQ:NCPL) stock broke to a new 52-week low of $0.42 on Friday. Shares of the company traded down 16.89%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $2.11 on Friday morning, moving down 3.77%.
    • Applied UV (NASDAQ:AUVI) shares set a new yearly low of $0.45 this morning. The stock was down 4.26% on the session.
    • Scinai Immunotherapeutics (NASDAQ:SCNI) shares fell to $0.95 on Friday, setting a new 52-week low with a shift of down 15.0%.
    • Baudax Bio (NASDAQ:BXRX) shares set a new 52-week low of $0.34. The stock traded down 2.53%.
    • RiceBran Tech (NASDAQ:RIBT) stock hit a yearly low of $0.45. The stock was down 7.16% for the day.
    • Allarity Therapeutics (NASDAQ:ALLR) shares were down 4.0% for the day, having made a 52-week low of $0.96.
    • Recruiter.Com Group (NASDAQ:RCRT) shares reached a new 52-week low of $1.42 on Friday morning, moving down 3.9%.
    • Blue Star Foods (NASDAQ:BSFC) stock set a new 52-week low of $0.35 on Friday, moving down 6.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $PLNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PLNT
    $PLRX
    $PMF
    $PML

    CompanyDatePrice TargetRatingAnalyst
    TKO Group Holdings Inc.
    $TKO
    2/27/2026Buy → Neutral
    Seaport Research Partners
    CAVA Group Inc.
    $CAVA
    2/27/2026Buy → Hold
    Argus
    TKO Group Holdings Inc.
    $TKO
    2/26/2026$235.00 → $250.00Buy
    Pivotal Research Group
    Realty Income Corporation
    $O
    2/25/2026$61.00 → $70.00Outperform
    RBC Capital Mkts
    Realty Income Corporation
    $O
    2/25/2026$67.75 → $70.50Buy
    Stifel
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    CAVA Group Inc.
    $CAVA
    2/25/2026$85.00 → $88.00Outperform
    Telsey Advisory Group
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Neutral
    Wedbush
    More analyst ratings

    $PLNT
    $PLRX
    $PMF
    $PML
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Nance Mark E covered exercise/tax liability with 3,368 shares and was granted 12,675 shares, increasing direct ownership by 13% to 81,252 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/27/26 4:19:22 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SVP, Strategy & Bus. Dev. Reis Mischa covered exercise/tax liability with 2,976 shares and was granted 5,915 shares, increasing direct ownership by 9% to 35,321 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/27/26 4:19:29 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    CFO Hartley Lindsey Marie was granted 17,453 shares and covered exercise/tax liability with 6,630 shares, increasing direct ownership by 24% to 55,276 units (SEC Form 4)

    4 - Axogen, Inc. (0000805928) (Issuer)

    2/27/26 4:21:45 PM ET
    $AXGN
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    SEC Filings

    View All

    Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

    8-K - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Filer)

    2/27/26 4:24:56 PM ET
    $BCLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form F-3/A filed by EZGO Technologies Ltd.

    F-3/A - EZGO Technologies Ltd. (0001806904) (Filer)

    2/27/26 4:16:19 PM ET
    $EZGO
    Motor Vehicles
    Consumer Discretionary

    SEC Form 6-K filed by Grupo Televisa S.A.B.

    6-K - GRUPO TELEVISA, S.A.B. (0000912892) (Filer)

    2/27/26 4:15:07 PM ET
    $TV
    Broadcasting
    Industrials

    $PLNT
    $PLRX
    $PMF
    $PML
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TKO Group Holdings downgraded by Seaport Research Partners

    Seaport Research Partners downgraded TKO Group Holdings from Buy to Neutral

    2/27/26 8:30:01 AM ET
    $TKO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    CAVA Group downgraded by Argus

    Argus downgraded CAVA Group from Buy to Hold

    2/27/26 8:26:41 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Pivotal Research Group reiterated coverage on TKO Group Holdings with a new price target

    Pivotal Research Group reiterated coverage of TKO Group Holdings with a rating of Buy and set a new price target of $250.00 from $235.00 previously

    2/26/26 6:55:05 AM ET
    $TKO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Minogue Michael R bought $499,847 worth of shares (2,030 units at $246.23) (SEC Form 4)

    4 - INSULET CORP (0001145197) (Issuer)

    2/26/26 7:05:23 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    President and CEO Mcevoy Ashley bought $1,029,205 worth of shares (4,300 units at $239.35), increasing direct ownership by 45% to 13,916 units (SEC Form 4)

    4 - INSULET CORP (0001145197) (Issuer)

    2/23/26 8:14:32 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    Large owner Opaleye Management Inc. bought $18,333 worth of Ordinary Shares (291 units at $63.00) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    2/18/26 4:05:16 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthpeak Properties, Inc. Announces Public Filing of Registration Statement with the SEC for Janus Living, Inc.

    Healthpeak Properties, Inc. (NYSE:DOC) today announced that Janus Living, Inc., a pure-play senior housing real estate investment trust ("REIT"), has publicly filed a registration statement on Form S-11 with the Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of its shares of Class A-1 common stock. The offering is subject to market conditions, receipt of regulatory approvals, completion of related financings, completion of the SEC's review, and other customary conditions, and there can be no assurance as to whether or when the offering may be commenced or completed. The number of shares to be offered and the price range and other terms for the

    2/27/26 5:30:00 PM ET
    $DOC
    Real Estate Investment Trusts
    Real Estate

    Macy's, Inc. Board of Directors Announces Increase to Quarterly Dividend

    The board of directors of Macy's, Inc. (NYSE:M) today declared a regular quarterly dividend of 19.15 cents per share on Macy's, Inc.'s common stock, an increase of 5%, payable on April 1, 2026, to shareholders of record at the close of business on March 13, 2026. About Macy's, Inc. Macy's, Inc. (NYSE:M) is a trusted source for quality brands through our iconic nameplates – Macy's, Bloomingdale's and Bluemercury. Headquartered in New York City, our comprehensive digital and nationwide footprint empowers us to deliver a seamless shopping experience for our customers. For more information, visit macysinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/

    2/27/26 12:37:00 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Macy's Launches "Celebrations Start at Macy's," a Year-Long Immersive Platform Bringing Life's Moments to the Center of Culture

    "Celebrations Start at Macy's" unites iconic traditions and everyday moments all year long, featuring exciting in-store events, immersive experiences and opportunities for everyone to be a part of the 100th Macy's Thanksgiving Day Parade® "Celebrations Start at Macy's" kicks-off on Saturday, March 7 with prom events nationwide Today, Macy's unveils "Celebrations Start at Macy's," a year-long platform designed to put Macy's at the center of customers' important moments. From everyday celebrations to once-in-a-lifetime milestones, Macy's inspires customers at every step of their journey. "Celebrations Start at Macy's" will come to life throughout the year for customers through immersive e

    2/27/26 11:00:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    $PLNT
    $PLRX
    $PMF
    $PML
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Chewy Appoints Chris Deppe as Chief Financial Officer

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D

    2/24/26 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors

    Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board Mechelen, Belgium; February 19, 2026, 22:01 CET — Galapagos NV ((Euronext &, NASDAQ:GLPG), today announced the appointment by way of co-optation of Dr. Paulo Fontoura as Non-Executive Independent Director to its Board of Directors, effective February 9, 2026. "We are pleased to welcome Paulo to our Board," said Jérôme Contamine, Chair of the Board of Galapagos. "His global leadership experience, deep understanding of clinical development strategy, and proven track record of assessing and advancing differentiated assets will strengthen the Board's ability to provide strategic guida

    2/19/26 4:01:00 PM ET
    $GLPG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Protara Therapeutics Inc.

    SC 13G - Protara Therapeutics, Inc. (0001359931) (Subject)

    12/17/24 4:02:03 PM ET
    $TARA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nuveen Core Plus Impact Fund

    SC 13D/A - Nuveen Core Plus Impact Fund (0001835068) (Subject)

    12/16/24 6:56:51 PM ET
    $NPCT
    Investment Managers
    Finance

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Financials

    Live finance-specific insights

    View All

    Macy's, Inc. Board of Directors Announces Increase to Quarterly Dividend

    The board of directors of Macy's, Inc. (NYSE:M) today declared a regular quarterly dividend of 19.15 cents per share on Macy's, Inc.'s common stock, an increase of 5%, payable on April 1, 2026, to shareholders of record at the close of business on March 13, 2026. About Macy's, Inc. Macy's, Inc. (NYSE:M) is a trusted source for quality brands through our iconic nameplates – Macy's, Bloomingdale's and Bluemercury. Headquartered in New York City, our comprehensive digital and nationwide footprint empowers us to deliver a seamless shopping experience for our customers. For more information, visit macysinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/

    2/27/26 12:37:00 PM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary

    Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

    FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.  Fourth Quarter 2025 Financial Highlights: Revenue was $61.5 million, a decrease of 1% from $62.3 million in Q4 2024.Net Loss, inclusive of goodwill impairment charges of $19.5 million, was $(17.1) million, or (28)% of revenue, compared to $(84.7) million in Q4 2024, inclusive of goodwill impairment charges of $97.1 million, or (136)% of revenue.Adjusted Net Income was $8.6 million, compared to $12.6 millio

    2/26/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    – Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 –  – Revuforj® (revumenib) net revenue of $44.2 million in 4Q25, a 38% increase vs 3Q25, and $124.8 million in FY2025 – – Niktimvo™ (axatilimab-csfr) net revenue of $56.0 million in 4Q25, a 22% increase vs 3Q25, and $151.6 million in FY2025, resulting in Syndax collaboration revenue of $42.4 million in FY2025 – – Completed enrollment in Phase 2 IPF trial of axatilimab; topline data expected in 4Q26 – – Company to host a conference call today at 4:30 p.m. ET – NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer ther

    2/26/26 4:01:00 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care